8 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
A Controlled Trial ... #EBM #Neuro #Erenumab ... #Migraine #CGRP ... #VisualAbstract ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
, According to Trial ... Group #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... #NEJM
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Summary of Major Clinical ... Trials - EGDT ... : NEJM 2001 - ... GoalDirected #Therapy #Trials ... #EBM #VisualAbstract
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Major Clinical Trials ... 2013 - UGIB TRISS ... ALI is the deadliest ... /vmoitra) #EBM ... Thresholds #Hematology #VisualAbstract
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
point of major or clinically ... that received triple ... warfarin (Panel A) #EBM ... #Cardiology #IM ... AtrialFibrillation #NEJM
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
Clinical Trial of ... NEJM 2018 https ... TessaRDavis #EBM ... #VisualAbstract ... Infusion #Rates #NEJM